Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc.
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental ...
FDA revamps peptide panel by appointing wellness clinic physicians to advise on pharmacy compounding of seven peptides, including BPC-157 and TB-500.
BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Alzheimer's Association International Conference (AAIC) ...
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”; “Rani” or the “Company”) (Nasdaq: RANI), a clinical-stage ...
The state will still allow lethal injection for death-row prisoners if it's not possible to use the firing squad.
Between disease, pesticide contamination and starvation, seabirds are fighting multiple battles along the California coastline this year.
High cholesterol despite taking statins? Cardiologist Dr Naveen Bhamri explains who may benefit from cholesterol-lowering ...
A massive marine heatwave off the West Coast is the biggest culprit behind this year’s mass strandings of pelicans, loons, ...
The FDA’s approval of inebilizumab has heralded a new era for patients with IgG4-related disease, while novel agents moving ...
The FDA’s extension will give reviewers more time to review a major amendment to Biogen and Eisai’s application for a subcutaneous induction formulation of Alzheimer’s therapy Leqembi. The new target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results